These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29355678)

  • 1. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations.
    Ghosh S; Carmo M; Calero-Garcia M; Ricciardelli I; Bustamante Ogando JC; Blundell MP; Schambach A; Ashton-Rickardt PG; Booth C; Ehl S; Lehmberg K; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2018 Sep; 142(3):904-913.e3. PubMed ID: 29355678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
    J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
    Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM
    Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.
    Tsoukas P; Rapp E; Van Der Kraak L; Weiss ES; Dang V; Schneider C; Klein E; Picarsic J; Salcedo R; Stewart CA; Canna SW
    Blood; 2020 Nov; 136(19):2162-2174. PubMed ID: 32589707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis.
    Tiwari S; Hontz A; Terrell CE; Arumugam P; Carmo M; Risma K; Jordan M; Malik P
    Hum Gene Ther; 2016 Oct; 27(10):847-859. PubMed ID: 27471778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
    Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
    Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency.
    Carmo M; Risma KA; Arumugam P; Tiwari S; Hontz AE; Montiel-Equihua CA; Alonso-Ferrero ME; Blundell MP; Schambach A; Baum C; Malik P; Thrasher AJ; Jordan MB; Gaspar HB
    Mol Ther; 2015 Apr; 23(4):737-45. PubMed ID: 25523759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
    Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
    Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.
    Landy E; Varghese J; Dang V; Szymczak-Workman A; Kane LP; Canna SW
    Blood Adv; 2023 Nov; 7(22):6949-6963. PubMed ID: 37738167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
    Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
    Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin is a critical physiologic regulator of T-cell activation.
    Lykens JE; Terrell CE; Zoller EE; Risma K; Jordan MB
    Blood; 2011 Jul; 118(3):618-26. PubMed ID: 21606480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.
    Sepulveda FE; Debeurme F; Ménasché G; Kurowska M; Côte M; Pachlopnik Schmid J; Fischer A; de Saint Basile G
    Blood; 2013 Jan; 121(4):595-603. PubMed ID: 23160464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice.
    Rothman JA; Das R; Teachey DT; Paessler ME; Nichols KE
    Pediatr Blood Cancer; 2011 Dec; 57(7):1239-43. PubMed ID: 21681935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
    Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
    Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.
    Jessen B; Maul-Pavicic A; Ufheil H; Vraetz T; Enders A; Lehmberg K; Längler A; Gross-Wieltsch U; Bay A; Kaya Z; Bryceson YT; Koscielniak E; Badawy S; Davies G; Hufnagel M; Schmitt-Graeff A; Aichele P; Zur Stadt U; Schwarz K; Ehl S
    Blood; 2011 Oct; 118(17):4620-9. PubMed ID: 21878672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.
    Terrell CE; Jordan MB
    Blood; 2013 Jun; 121(26):5184-91. PubMed ID: 23660960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
    Dettmer-Monaco V; Weißert K; Ammann S; Monaco G; Lei L; Gräßel L; Rhiel M; Rositzka J; Kaufmann MM; Geiger K; Andrieux G; Lao J; Thoulass G; Schell C; Boerries M; Illert AL; Cornu TI; Ehl S; Aichele P; Cathomen T
    J Allergy Clin Immunol; 2024 Jan; 153(1):243-255.e14. PubMed ID: 37595758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.
    Meyer LK; Verbist KC; Albeituni S; Scull BP; Bassett RC; Stroh AN; Tillman H; Allen CE; Hermiston ML; Nichols KE
    Blood; 2020 Aug; 136(6):657-668. PubMed ID: 32530039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.